News

A black box warning, also called a boxed warning, was issued by the FDA in March 2020 about mental health side effects with Singulair, also known by its generic name, montelukast -- a 25-year-old ...
In 2020, the FDA did issue a “black box warning” for Singulair. That’s the FDA’s highest safety-related medication warning, but as a New York Times investigation showed last week, ...
Research sheds light on effectiveness of FDA's black box warning for Singulair. University of Oklahoma. DOI 10.5863/1551-6776-28.8.704. Keywords ...
Overall, prescriptions for Singulair have decreased only slightly since the black box warning was issued. In February, the New York attorney general cited the OU findings among other research in a ...
A University of Oklahoma study about a "black box warning" for the asthma drug Singulair continues to influence a national conversation about the medication and its reported neuropsychiatric side ...
The reports and new scientific research led the FDA in 2020 to add a "black box" warning to the montelukast prescribing label, flagging serious mental health risks like suicidal thinking or actions.
Montelukast (Singulair) held no elevated risk of depression, anxiety, suicidality, or behavioral problems for children, according to a new study that throws further doubt on the black box warning ...
Parents who argue Singulair endangered their children view the FDA’s 2020 decision to add a black box warning as vindication, but many still want to sue Merck for not acting sooner.
A new black box warning will be added to an asthma drug which has been linked to reports of three suicides in Australia during the past year. ... also known by its brand name Singulair. (Supplied: ...
The New York attorney general’s office is asking the Food and Drug Administration (FDA) to double down on its warnings and discourage the use of an asthma drug. “The New York Office of the ...
A University of Oklahoma study about a “black box warning” for the asthma drug Singulair continues to influence a national conversation about the medication and its reported neuropsychiatric side ...